Johnson & Johnson raises FY2026 operational sales growth outlook to 6.7% — 7.1%

Johnson & Johnson raised 2026 operational sales growth guidance to 6.7%-7.1%, implying USD 100.7 billion at the midpoint. Reported sales growth forecast lifted to 7.2%-7.6%, implying USD 101.2 billion at the midpoint, based on a USD 1.15 average euro rate. Adjusted operational EPS outlook set at USD 10.95-11.05; reported adjusted EPS forecast at USD 11.05-11.15, midpoint USD 11.10. Free cash flow guidance maintained at about USD 21 billion; Q3 free cash flow exceeded USD 6 billion. Operating margin expected to fall about 60 basis points; net interest expense seen at USD 150 million-200 million; tax rate 17.0%-17.5%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein. (C)